Jonathan Marks. The Perils of Partnership: Industry Influence, Institutional Integrity, and Public Health. Oxford University Press, 2019.
I blurbed this one:
Jonathan Marks is the go-to expert on the hazards of public-private partnerships. His account of the perils reads easily, is well referenced, is clear and to the point, and applies to partnerships with drug, food, and any other corporations. Anyone who cares about the ethical implications of such partnerships for public health will find this book invaluable.
The book is about industry partnerships in general, but Marks uses food-company examples such as the American Beverage Association’s gift to the Children’s Hospital of Pennsylvania in what seemed to be a direct exchange for the city’s dropping a soda tax initiative, and the USDA’s promotion of cheese.
Marks concludes that
Public-private partnerships, multistakeholder initiatives, and other close relations with industry are premised on a positive conception of consensus, compromise, and collaboration. But the “three C’s” are not inherently good. On the contrary, tension between regulators and corporations is ordinarily necessary to protect public health. And achieving common ground with industry may put off the table measures that might promote public health. The default relation between industry and government should be arm’s lengths relations involving institutional tension, “struggle,” and direct conflict.
The point: the agenda of corporations is to promote profit, not public health. This creates an inherent tension, not easily resolved.